Skip to content

Clinical trials

Phase 3 Immunoglobulin Light-chain Amyloidosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoglobulin Light-chain Amyloidosis Phase: Phase 3 Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20031
20052
20061
20072
20082
20091
20101
20111
20152
20202
20232
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated2
Unknown status2
Active, not recruiting2
Recruiting1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.2
Alliance for Clinical Trials in Oncology2
Jonsson Comprehensive Cancer Center2
Mayo Clinic2
Memorial Sloan Kettering Cancer Center2
AbbVie1
Air Force Military Medical University, China1
Boston Medical Center1
Case Comprehensive Cancer Center1
European Myeloma Network B.V.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoglobulin Light-chain Amyloidosis28
Multiple Myeloma15
Hodgkin Disease13
Immunoblastic Lymphadenopathy13
Leukemia, Lymphocytic, Chronic, B-Cell13
Lymphoma, Follicular13
Lymphoma, Large B-Cell, Diffuse13
Lymphoma, Large-Cell, Anaplastic13
Lymphoma, Large-Cell, Immunoblastic13
Lymphoma, Mantle-Cell13

Trials

Showing 51 to 28 of 28. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.